Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
7.68
-0.02 (-0.26%)
At close: Jan 2, 2026, 4:00 PM EST
7.72
+0.04 (0.52%)
After-hours: Jan 2, 2026, 5:40 PM EST

Fennec Pharmaceuticals Revenue

Fennec Pharmaceuticals had revenue of $12.46M in the quarter ending September 30, 2025, with 78.69% growth. This brings the company's revenue in the last twelve months to $38.79M, down -21.39% year-over-year. In the year 2024, Fennec Pharmaceuticals had annual revenue of $47.54M with 123.69% growth.

Revenue (ttm)
$38.79M
Revenue Growth
-21.39%
P/S Ratio
5.47
Revenue / Employee
$1,212,188
Employees
32
Market Cap
262.30M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202447.54M26.29M123.69%
Dec 31, 202321.25M19.72M1,284.50%
Dec 31, 20221.54M--
Dec 31, 2021---
Dec 31, 2020170.00K--
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro